KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShares Repurchased
Ratios

Fulgent Genetics (FLGT) Leases (2019 - 2025)

Historic Leases for Fulgent Genetics (FLGT) over the last 7 years, with Q3 2025 value amounting to $5.0 million.

  • Fulgent Genetics' Leases fell 1708.54% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 1708.54%. This contributed to the annual value of $5.4 million for FY2024, which is 5022.14% down from last year.
  • Per Fulgent Genetics' latest filing, its Leases stood at $5.0 million for Q3 2025, which was down 1708.54% from $4.8 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Leases peaked at $18.0 million during Q2 2022, and registered a low of $928000.0 during Q1 2021.
  • In the last 5 years, Fulgent Genetics' Leases had a median value of $7.5 million in 2021 and averaged $8.9 million.
  • Data for Fulgent Genetics' Leases shows a peak YoY increase of 76243.96% (in 2021) and a maximum YoY decrease of 6324.75% (in 2021) over the last 5 years.
  • Over the past 5 years, Fulgent Genetics' Leases (Quarter) stood at $7.1 million in 2021, then skyrocketed by 107.03% to $14.8 million in 2022, then fell by 26.69% to $10.8 million in 2023, then tumbled by 50.22% to $5.4 million in 2024, then dropped by 8.25% to $5.0 million in 2025.
  • Its Leases stands at $5.0 million for Q3 2025, versus $4.8 million for Q2 2025 and $5.1 million for Q1 2025.